TOKYO INSTITUTE OF TECHNOLOGY, Chemical Resources Laboratory, Synthetic Organic Division, Nakamura & Okada Laboratory

Papers (2001〜2010)

2010・2009・2008・2007・2006・2005・2004・2003・2002・2001

    2010

        1. H. Nakamura,
          “Minimally Invasive Cytoselective Radiation Therapy Using Boron Neutron Capture Reaction” YAKUGAKU ZASSHI 130(12) 1687-1694 (2010).
        2. K. Ishihara, S. Okuyama, S. Kumano, K. Iida, H. Hamana, M. Murakoshi, T. Kobayashi, S. Usami, K. Ikeda, Y. Haga, K. Tsumoto, H. Nakamura, N. Hirasawa, H. Wada,”Salicylate Restores Transport Function and Anion Exchanger Activity of Missense Pendrin Mutations” Hearing Res., 270, 110-118 (2010). LINK
        3. 中村浩之”ホウ素の中性子捕捉反応を利用した低侵襲細胞選択的放射線療法” Yakugaku Zasshi 130, 1687-1694 (2010). LINK
        4. H. Nakamura, R. Horikoshi, T. Usui, H. S. Ban,”Selective Inhibition of EGFR and VEGFR2 Tyrosine Kinases Controlled by a Boronic Acid Substituent on 4-Anilinoquinazolines”, Med. Chem. Commun., 1, 282-286 (2010). LINK One of the top ten accessed articles from the online version of MedChemComm in the Royal Cemical Society journals!
        5. H. S. Ban, K. Shimizu, H. Minegishi, H. Nakamura, “Identification of HSP60 as a Primary Target of ortho-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor”, J. Am. Chem. Soc., 132(34), 11870-11871 (2010). LINK
        6. 上野学、潘鉉承、中村浩之”リポソームを用いる中性子捕捉治療” Drug Delivery System, 25(5), 474-482 (2010). LINK
        7. A. R. Genady, H. Nakamura,”Undecahydro-closo-dodecaborates as Good Leaving Groups in Organic Synthesis: Generation of Substituted Styrenes via Elimination of Arylethyl Dodecaborates”, Org. Biomol. Chem. 8, 4427-4435 (2010). LINK
        8. 中村浩之”中性子捕捉治療のためのナノカプセル型ホウ素薬剤送達システム（BDS）の開発” Pharm. Tech. Japan, 26, 1005-1012 (2010). LINK
        9. H. S. Ban, H. Minegishi, K. Shimizu, M. Maruyama, Y. Yasui, H. Nakamura,”Discovery of Carboranes as Inducers of 20S Proteasome Activity”, ChemMedChem. 5(8), 1236-1241 (2010). LINK
        10. M. E. El-Zaria, A. R. Genady, H. Nakamura, “Synthesis of Triazolyl Methyl-substituted Amino- and Oxy-undecahydrododecaborates for Potential Application in Boron Neutron Capture Therapy”,New J. Chem. 34, 1612-1622 (2010). LINK
        11. T. Sugiishi, A. Kimura, H. Nakamura,”Copper(I)-Catalyzed Substitution Reactions of Propargylic Amines: Importance of Csp-Csp3 Bond Cleavage in Generation of Iminium Intermediates”, J. Am. Chem. Soc. , 132(15), 5332-5333 (2010). LINK
        12. H. S. Ban, M. Uno, H. Nakamura,”Suppression of Hypoxia-induced HIF-1α Accumulation by VEGFR Inhibitors: Different Profiles of AAL993 versus SU5416 and KRN633″, Cancer Lett. 296(1), 17-26 (2010). LINK
        13. M. Ueno, H. S. Ban, K. Nakai, Y. Kaneda, A. Matsumura, H. Nakamura,”closo-Dodecaborate Lipid Liposomes as New Boron Delivery Vehicles for Neutron Capture Therapy of Cancers”, Bioorg. Med. Chem. 18, 3059-3065 (2010).
        14. K. Shimizu, M. Maruyama, Y. Yasui, H. Minegishi, H. S. Ban, H. Nakamura,”Boron-Containing Phenoxyacetanilide Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors”,Bioorg. Med. Chem. Lett., 20(4), 1453-1456 (2010). LINK
        15. H. S. Ban, Y. Tanaka, W. Nabeyama, M. Hatori, H. Nakamura, “Enhancement of EGFR Tyrosine Kinase Inhibition by C-C Multiple Bonds-Containing Anilinoquinazolines”, Bioorg. Med. Chem. 18(2), 870-879 (2010). LINK
        16. M. E. El-Zaria, H. S. Ban, H. Nakamura,”Boron-Containing Protoporphyrin IX Derivatives and Their Modification for Boron Neutron Capture Therapy: Synthesis, Characterization, and Comparative In Vitro Toxicity Evaluation”, Chem. Eur. J. 16(5), 1543-1552 (2010). LINK

    2009

        1. M. E. El-Zaria, H. Nakamura,”New Strategy for Synthesis of Mercaptoundecahydrododecaborate Derivatives via Click Chemistry: Possible Boron Carriers and Visualization in Cells for Neutron Capture Therapy”, Inorg. Chem. 48(24), 11896-11902 (2009). LINK
        2. C.-H. Lee, G. F. Jin, J. G. Joung, J.-D. Lee, H. S. Ban, H. Nakamura, J.-K. Cho, S. O. Kang,”New Types of Potential BNCT Agents, o-Carboranyl Aminoalcohols”, Tetrahedron Lett., 50(24), 2960-2963 (2009). LINK
        3. H. S. Ban, T. Usui, W. Nabeyama, H. Morita, K. Fukuzawa, H. Nakamura,”Discovery of Boron-Conjugated 4-Anilinoquinazoline as a Prolonged Inhibitor of EGFR Tyrosine Kinase”, Org. Biomol. Chem. 7(21), 4415-4427 (2009). LINK
        4. H. Nakamura, M. Watanabe, H. S. Ban, A. Asai,”Synthesis and Biological Evaluation of Boron Peptide Analogues of Belactosin C as Proteasome Inhibitors”, Bioorg. Med. Chem. Lett. 19(12), 3220-3224 (2009). LINK
        5. M. Uno, H. S. Ban, H. Nakamura,”Discovery of 1-[4-(N-Benzylamino)phenyl]-3-phenylurea Derivatives as a  ew Class of Hypoxia-Inducible Factor-1α Inhibitors”, Bioorg. Med. Chem. Lett. 19(12), 3166-3169 (2009). LINK
        6. H. Nakamura, M. Ueno, H. S. Ban, K. Nakai, K. Tsuruta, Y. Kaneda, A. Matsumura,”Development of Boron Nano Capsules for Neutron Capture Therapy”, Appl. Radiat. Isotope. 67. S84-S87 (2009). LINK

    2008

        1. C.-H. Lee, G. F. Jin, H.-S. Kim, H. Nakamura, J.-D. Lee,”Synthesis and Characterization of o-Carboranylthiolate Substituted 1,3,5-Triazines”, Bull. Korean Chem. Soc. 29(3), 697-700 (2008). LINK
        2. C.-H. Lee, G. F. Jin, H.-S. Kim, H. Nakamura, Y. Chung, J.-D. Lee,”Preparation of Boronated Heterocyclic Compounds Using Intramolecular Cyclization Reaction”, Bull. Korean Chem. Soc. 29(2), 357-362 (2008). LINK
        3. H. Nakamura,
          “Development of Boron Delivery System for Neutron Capture Therapy of Cancer”, Progress in Drug Delivery System XVII, 19-24 (2008).
        4. H. Nakamura, T. Sugiishi, Y. Tanaka,
          “Synthesis of Allenes via CuBr-catalyzed Homologation of Alk-1-ynes Accelerated by Microwave”, Tetrahedron Lett. 49(50), 7230-7233 (2008). LINK
        5. I. Ryu, H. Matsubara, H. Nakamura, D. P. Curran,
          “Phase-Vanishing Methods Based on Fluorous Phase Screen. A Simple Way for Efficient Execution of Organic Synthesis”, Chem. Rec. 8(6), 351-363 (2008). LINK
        6. N. Sogabe, K. Oda, H. Nakamura, H. Orimo, H. Watanabe, T. Hosoi, M. Goseki-Sone,
          “Molecular Effects of the Tissue-Nonspecific Alkaline Phosphatase Gene Polymorphism (787T>C) Associated with Bone Mineral Density”, Biomed. Res. 9(4), 213-219 (2008). LINK
        7. 中村浩之
          “がん中性子捕捉療法と次世代ホウ素デリバリーシステム”, 臨床血液 (invited), 49(5), 294-301 (2008). LINK
        8. H. S. Ban, S. Onagi, M. Uno, W. Nabeyama, H. Nakamura,
          “Allene as an Alternative Functional Group for Drug Design: Effect of C-C Multiple Bonds Conjugated with Quinazolines on EGFR Tyrosine Kinase Inhibition”, ChemMedChem, 3, 1094-1103 (2008). LINK
        9. H. Nakamura, H. Saito, M. Nanjo,
          “Synthesis of 1,2-Dihydroisoquinolines via Palladium (0)-Catalysed Addition-Cycloaddition of Pronucleophiles to ortho-Alkynylaldimines”, Tetrahedron Lett., 49, 2697-2700 (2008). LINK
        10. H. Nakamura, M. Ishikura, T. Sugiishi, T. Kamakura, J-F. Biellmann,
          “Synthesis of Mono- and 1,3-Disubstituted Allenes from Propargylic Amines via Palladium-Catalysed Hydride-Transfer Reaction”, Org. Biomol. Chem. 6, 1471-1477 (2008). LINK
        11. M. Uno, H. S. Ban, W. Nabeyama, H. Nakamura,
          “De novo Design and Synthesis of N-Benzylanilines as New Candidates for VEGFR Tyrosine Kinase Inhibitors”, Org. Biomol. Chem. 6, 979-981 (2008). LINK Selected in the RSC’s Chemical Biology Research Articles!
        12. H. Nakamura
          “Liposomal Boron Delivery System for Neutron Capture Therapy”, YAKUGAKU ZASSHI, 128(Review), 193-208 (2008). LINK
        13. C.-H. Lee, G. F. Jin, J. H. Yoon, Y. J. Jung, J.-D. Lee, S. Cho, H. Nakamura, S. O. Kang,
          “Synthesis and Characterization of Polar Functional Group Substituted Mono- and Bis-(o-carboranyl)-1,3,5-triazine Derivatives”, Tetrahedron Lett., 49, 159-164 (2008). LINK
        14. T. Usui, H. S. Ban, J. Kawada, T. Hirokawa, H. Nakamura,
          “Discovery of Indenopyrazoles as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors by in silico High-Throughput Screening”, Bioorg. Med. Chem. Lett., 18, 285-288 (2008). LINK

    2007

        1. H. Nakamura, J.-D. Lee, M. Ueno, Y. Miyajima, H. S. Ban,
          “Synthesis of closo-Dodecaboryl Lipids and Their Liposomal Formation for Boron Neutron Capture Therapy”, NanoBiotechnology (invited), 3, 135-145 (2007). LINK
        2. H. Nakamura, M. Ueno, J.-D. Lee, H. S. Ban, E. Justus, P. Fan, D. Gabel,
          “Synthesis of Dodecaborate-Conjugated Cholesterols for Efficient Boron Delivery in Neutron Capture Therapy”, Tetrahedron Lett. 48, 3151-3154 (2007). LINK
        3. J.-D. Lee, M. Ueno, Y. Miyajima, H. Nakamura,
          “Synthesis of Boron Cluster Lipids: closo-Dodecaborate as an Alternative Hydrophilic Function of Boronated Liposomes for Neutron Capture Therapy”, Org. Lett. 9, 323-326 (2007). LINK

    2006

        1. J-D. Lee, H. Nakamura,
          “Synthesis and Liposome Formation of B-10 Enriched B12H11S-Substituted Lipid for Boron Delivery System on BNCT”, Advances in Neutron Capture Therapy, 238-241 (2006).
        2. H. Nakamura, Y. Miyajima, Y. Kuwata, S. Masunaga, K. Ono, K. Maruyama,
          “Transferrin-Loaded nido-Carborane Liposomes: Synthesis and Intracellular Targeting to Solid Tumors for Boron Neutron Capture Therapy”, Advances in Neutron Capture Therapy, 195-198 (2006).
        3. A. Matsumura, Y. Mori, Y. Kaneda, K. Hashimoto, K. Nakai, T. Yamamoto, H. Nakamura, K. Akamatsu, T. Asano,S. Lee, Y. Sakurai, H. Kumada, K. Yamamoto, Y. Shibata, T. Shibata, T. Nakahara, M. Mutoh, H. Sakae, Y. Yuasa,Y. Satoh, H. Sakurabata, S. Muraki, T. Nagayama,
          “A New NEDO Reseach Project Toward Hospital Based Accelerator BNCT using Advanced DDS system”, Advances in Neutron Capture Therapy, 74-76 (2006).
        4. H. Nakamura, T. Usui, R. Horikoshi, W. Nabeyama, H. S. Ban,
          “Selective Inhibition of EGFR and VEGER Tyrosine Kinases Controlled by a Boronic Acid Substituent on 4-Anilinoquinazolines”, YAKUGAKU ZASSHI, 126, 164-165 (2006).
        5. H. Nakamura, Y. Sasaki, M. Uno, T. Yoshikawa, T. Asano, H. S. Ban, H. Fukazawa, M. Shibuya, Y. Uehara,
          “Synthesis and Biological Evaluation of Benzamides and Benzamidines As Selective Inhibitors of VEGFR Tyrosine Kinases”, Bioorg. Med. Chem. Lett. 16, 5127-5131 (2006). LINK
        6. Y. Miyajima, H. Nakamura, Y. Kuwata, J-D. Lee, S. Masunaga, K. Ono, K. Maruyama,
          “Transferrin-Loaded nido-Carborane Liposome: Synthesis and Intracellular Targeting to Solid Tumors for Boron Neutron Capture Therapy”, Bioconjugate Chem., 17, 1310-1320 (2006). LINK Highlighted in the NIH Alliance for Nanotechnology in Cancer, Nanotech, 2006, September 5.
        7. H. Nakamura, H. Kuroda, H. Saito, R. Suzuki, T. Yamori, K. Maruyama, T. Haga,
          “Synthesis and Biological Evaluation of Boron Containing cis-Stilbenes as Apoptotic Tubulin Polymerization Inhibitors”, ChemMedChem 1, 729-740 (2006). LINK
        8. H.Nakamura, T. Kamakura, S. Onagi,
          “1,2-Bis(diphenylphosphino)carborane As a Dual Mode Ligand for both the Sonogashira Coupling and Hydride-Transfer Steps in Palladium-Catalyzed One-Pot Synthesis of Allenes from Aryl Iodides”, Org. Lett. 8, 2095-2098 (2006). LINK
        9. H. Nakamura, S. Onagi,
          “Synthesis and Biological Evaluation of Allenic Quinazolines Using Palladium-Catalyzed Hydride-Transfer Reaction”, Tetrahedron Lett., 47, 2539-2542 (2006). LINK
        10. C-H. Lee, J. M. Oh, J-D. Lee, H. Nakamura, S. O. Kang,
          “Synthesis of Water Soluble THIQ Derivatives as Potential Boron Neutron Capture Therapy Agents: N-Functionalized o-Carboranylmethylbenzopiperidines”, Synlett., 275-278 (2006). LINK

    2005

        1. H. Nakamura, S. Tashiro, T. Kamakura,
          “Synthesis of Ene-Allenes via Palladium-Catalyzed Hydride-Transfer Reaction of Propargylic Amines under Mild Conditions”, Tetrahedron Lett., 28, 8333-8336 (2005). LINK
        2. 中村浩之
          “ドッキングシミュレーションによるキナーゼ阻害剤の分子設計”, ファルマシア, 最前線, 12月号, 749-753 (2005).
        3. H. Nakamura, Y. Miyajima, Y. Kuwata, S. Masunaga, K. Ono, K. Maruyama,
          “Transferrin-Conjugated Boron Liposomes as a Potent Boron Delivery System for Neutron Capture Therapy”, Progress in Drug Delivery System XIV, 45-53 (2005).
        4. H. Nakamura, S. Onagi, T. Kamakura,
          “Synthesis of Hetrocyclic Allenes via Palladium-Catalyzed Hydride-Transfer Reaction of Propargylic Amines”, J. Org. Chem. 70, 2359-2360 (2005). LINK
        5. M. Goseki-Sone, N. Sogabe, M. Fukushi-Irie, L. Mizoi, H. Orimo, T. Suzuki, H. Nakamura, H. Orimo, T. Hosoi,
          “Functional Analysis of the Single-nucleotide Polymorphism (787T>C) in Tissue-nonspecific Alkaline Phosphatase Gene Associated with Born Mineral Density”, J. Born Miner. Res. 20, 773-782 (2005). LINK
        6. K. Takahashi, H. Nakamura, S. Fukumoto, K. Yamamoto, H. Fukuda, A. Matsumura, Y. Yamamoto,
          “Synthesis and in vivo biodistribution of BPA-Gd-DTPA Complex as a Potential MRI Contrast Carrier for Neutron Capture Thereapy”, Bioorg. Med. Chem., 13, 735-743, (2005). LINK

    2004

        1. I. Ryu, H. Matsubara, H. Nakamura, D. P. Curran,
          “trans-1,2-Dibromocyclohexane. The Phase Vanishing Bromination with FC-72 as a Screen Phase”, In The Handbook of Fluorous Chemistry, J. A. Gladysz, D. P. Curran, I. T. Horvath, Eds. Wiley-VCH, Weinheim, (2004). Ch 11.46, 468-470. LINK
        2. H. Nakamura, Y. Miyajima, T. Takei, S. Kasaoka, K. Maruyama,
          “Synthesis and Vesicle Formation of a nido-Carborane Cluster Lipid for Boron Neutron Capture Therapy”, Progress in Drug Delivery System XIII, 85-94 (2004). LINK
        3. M. Ohtaka, H. Nakamura, Y. Yamamoto,
          “Synthesis of 1,2-dihydroisoquinolines via the reaction of ortho-alkynylarylimines with bis-π-allylpalladium”, Tetrahedron Lett., 45, 7339-7341 (2004). LINK
        4. H. Nakamura, Y. Miyajima, T. Takei, S. Kasaoka, K. Maruyama,
          “Synthesis and Vesicle Formation of a nido-Carborane Cluster Lipid for Boron Neutron Capture Therapy”, Chem. Commun., 1910-1911 (2004). LINK Selected as “Hot Paper” and introduced in the RSC’s Chemical Science, 2004, 1, C65.
        5. C-H. Lee, I. D. Yang, J-D. Lee, H. Nakamura, S-O. Kang,
          “Synthesis of N-Functionalized 3,4-o-Carboranylenepiperidines as Potential Boron Neutron Capture Therapy Agents”, Synlett., 1799-1801 (2004). LINK
        6. T. Asano, T. Yoshikawa, T. Usui, H. Yamamoto, Y. Yamamoto, Y. Uehara, H. Nakamura,
          “Benzamides and Benzamidines as Specific Inhibitors of Epidermal Growth Factor Receptor and v-Src Protein Tyrosine Kinases”, Bioorg. Med. Chem., 12, 3529-3542 (2004). LINK
        7. H. Nakamura, T. Kamakura, M. Ishikura, J-F. Biellmann,
          “Synthesis of Allenes via Palladium-Catalyzed Hydrogen Transfer Reactions: Propargylic Amines As an Allenyl Anion Equivalent”, J. Am. Chem. Soc., 126, 5958-5959 (2004).
        8. T. Asano, T. Yoshikawa, H. Nakamura, Y. Uehara, Y. Yamamoto,
          “Synthesis and Biological Evaluation of Benzamindes and Benzamidines: Structural Requirement of a Pyrimidine Ring for Inhibition of EGFR Tyrosine Kinase”, Bioorg. Med. Chem. Lett., 14, 2299-2302 (2004). LINK
        9. T. Asano, H. Nakamura, Y. Uehara, Y. Yamamoto,
          “Design, Synthesis, and Biological Evaluation of Aminoboronic Acids as Growth Factor Receptor Inhibitors for EGFR and Flt-1 Tyrosine Kinases”, ChemBioChem, 5, 483-490 (2004). LINK

    2003

        1. H-G. Lim, J-D. Lee, Y-J. Lee, C-H. Lee, J. Ko, H. Nakamura, S-O. Kang,
          “o-Carboranyl Derivatives of 1,3,5-s-Triazines: Structures, Properties, and in vitro Activities”, Appl. Organometal. Chem. , 17, 539-548 (2003). LINK
        2. H. Nakamura, T. Usui, H. Kuroda, I. Ryu, H. Matsubara, S. Yasuda, D. P. Curran,
          “A Fluorous Solvent as a New Phase-Screen Medium between Reagents and Reactants in the Bromination and Chlorination of Alcohols”, Org. Lett., 5, 1167-1169 (2003).

    2002

        1. I. Ryu, H. Matsubara, S. Yasuda, H. Nakamura, D. P. Curran,
          “Phase-Vanishing Reactions that Use Fluorous Media as a Phase Screen. Facile, Controlled Bromination of Alkenes by Dibromine and Dealkylation of Aromatic Ethers by Boron Tribromide”, J. Am. Chem. Soc., 124, 12946-12947 (2002) LINK
        2. H. Nakamura, M. Ohtaka, Y. Yamamoto,
          “Tandem Nucleophilic Allylation-Alkoxyallylation of Alkynylaldehydes via Amphiphilic Bis-p-allylapalladium Complexes”, Tetrahedron Lett., 43, 7631-7633 (2002). LINK
        3. J-D. Lee, C-H. Lee, H. Nakamura, J. Ko,S-O.Kang,
          “A Convenient Synthesis of the Novel carboranyl-substituted Tetrahydroisoquinolines: Application to the Biologically Active Agent for BNCT”, Tetrahedron Lett., 43, 5483-5486 (2002).
        4. K. Aoyagi, H. Nakamura, Y. Yamamoto,
          “Palladium-Catalyzed Aminoallylation of Activated Olefins with Allylic Halides and Certain Amines”, J. Org. Chem., 67, 5977-5980 (2002). LINK
        5. Bao, H. Nakamura, A. Inoue, Y. Yamamoto,
          “Nucleophilic Allylation-Heterocyclization via Bis-p-allylpalladium Complexes: Synthesis of Five- and Six-Membered Heterocycles”, Chem. Lett., 158-159 (2002). LINK
        6. H.-G. Lim, J.-D. Lee, Y.-J. Lee, C.-H. Lee, H. Nakamura, S.-H. C.-H. Lee, B. Jun, J. Ko, S.-O. Kang,
          “o-Carboranyl derivatives of 1,3,5-triazines”, Research and Development in Neutron Capture Therapy, W. Sauerwein, R. Moss, A. Wittig, Eds., Monduzzi, Bologna, 37-42 (2002).
        7. J-D. Lee, C-H. Lee, H. Nakamura, S-H. Lee, C-H. Lee, B. Jun, J. Ko, S-O. Kang,
          “Synthesis of carboranyl derivatives of a tetrahydroisoquinoline”, Research and Development in Neutron Capture Therapy, W. Sauerwein, R. Moss, A. Wittig, Eds., Monduzzi, Bologna, 31-35 (2002).
        8. L.F. Tietze, U. Griesbach, U. Bothe, H. Nakamura, Y. Yamamoto,
          “Novel Carboranes with a DNA Binding Unit for the Treatment of Cancer by Boron Neutron Capture Therapy”, ChemBioChem, 3, 219-225 (2002).

    2001

        1. M. Sekido, K. Aoyagi, H. Nakamura, C. Kabuto, Y. Yamamoto,
          “Formation of Cyclic Ethers via the Palladium-Catalyzed Cycloaddition of Activated Olefins with Allylic Carbonates Having a Hydroxy Group at the Terminus of the Carbon Chain”, J. Org. Chem., 66, 7142-7147 (2001). LINK
        2. H. Nakamura, B. Linclau, D. P. Curran,
          “Fluorous Triphasic Reactions: Transportative Deprotection of Fluorous Silyl Ethers with Concomitant Purification”, J. Am. Chem. Soc., 123, 10119-10120 (2001). LINK
        3. L. F. Tietze, U. Bothe, U. Griesbach, M. Nakaichi, T. Hasegawa, H. Nakamura, Y. Yamamoto,
          “ortho-Carboranyl Glycosides for the Treatment of Cancer by Boron Neutron Capture Therapy”, Bioorg. Med. Chem., 9, 1747-1752 (2001). LINK
        4. H . Nakamura, B. Ming, Y. Yamamoto,
          “The Fate of Bis-p-allylpalladium Complexes in the Co-existence of Aldehydes (or Imines) and Allylic Chlorides. Stille Coupling versus Allylation of Aldehydes (or Imine)”, Angew. Chem. Int. Ed. Engl., 40, 3208-3210 (2001). LINK
        5. L. F. Tietze, U. Bothe, U. Griesbach, M. Nakaichi, T. Hasegawa, H. Nakamura, Y. Yamamoto,
          “Carboranyl Bisglycosides for the Treatment of Cancer by Boron Neutron Capture Therapy”, ChemBioChem, 2, 326-334 (2001). LINK
        6. B. Ming, H. Nakamura, Y. Yamamoto,
          “Facile Allylative Dearomatization Catalyzed by Palladium”, J. Am. Chem. Soc., 123, 759-760 (2001). LINK
        7. H. Nakamura, K. Aoyagi, J. Shim, Y. Yamamoto,
          “Catalytic Amphiphilic Allylation via Bis-p-allylpalladium Complexes and Its Application to the Synthesis of Medium-Sized Carbocycles”, J. Am. Chem. Soc., 123, 372-377 (2001). LINK
        8. H. Nakamura, M. Fujiwara, Y. Yamamoto,
          “A Concise Synthesis of Chiral L-(4-Boronophenyl)alanine from L-Tyrosine”, Frontiers in Neutron Capture Therapy, Eds M. F. Hawthorn, K. Shelly, R. J. Wiersema, Kluwer Academic/Plenum Publishers, 765-768, New York (2001).
        9. T. Hasegawa, M. Nakaichi, S. Nakama, H. Nakamura, Y. Yamamoto, M. Takagaki, A. Takeuchi,
          “In vitro Uptake Study of 5-Carboranyluridine and Its Derivatives”, Frontiers in Neutron Capture Therapy, Eds M. F. Hawthorn, K. Shelly, R. J. Wiersema, Kluwer Academic/Plenum Publishers, 1003-1008, New York (2001).

             

      PAGETOP
      Copyright © Nakamura & Okada Labo. All Rights Reserved.
      Powered by WordPress & BizVektor Theme by Vektor,Inc. technology.